Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide [Phase 2]

View source ↗

Summary

A Phase 2 pilot clinical trial evaluating semaglutide for alcohol use disorder in people with HIV, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Yale University | Conditions: Alcohol Use Disorder (AUD), HIV | Phase 2 | Status: RECRUITING